London: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held ...

The global anti-osteoporosis therapy and fracture healing market is poised for remarkable growth, with projections indicating a rise from USD 14,051.6 million in 2023 to USD 22,427.6 million by 2033, ...

Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

The UK High Court has ruled that two GSK respiratory syncytial virus (RSV) vaccine patents are invalid in an action involving ...

ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries: London, UK Wednesday, October 9, 2024, 12:00 Hrs [IST] GSK plc announced that ...

This report highlights major developments in the health sector, including WeightWatchers offering a new obesity drug, Danco ...

Current health news highlights WeightWatchers offering a compound version of Novo Nordisk's obesity drug, Danco seeking FDA ...

DelveInsight's CD47 Inhibitors Market Insights report includes a comprehensive understanding of current treatment practices, ...

Meanwhile, demand for vaccines targeting respiratory syncytial virus are down in the U.S. Also, if you are uncertain about whether you might have covid or the flu, the newly approved at-home Healgen ...

Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced that it has engaged Philippe ...